Harry Gillis
Stock Analyst at Berenberg Bank
(4.70)
# 782
Out of 5,099 analysts
94
Total ratings
75%
Success rate
23.8%
Average return
Main Sectors:
Stocks Rated by Harry Gillis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Reiterated: Buy | kr 570.00 → kr 600.00 | kr 477.40 | +25.68% | 29 | Nov 2, 2026 | |
| ETR: FRE Fresenius SE & Co. KGaA | Reiterated: Buy | €54.00 | €48.81 | +10.63% | 1 | Oct 23, 2026 | |
| QGEN Qiagen | Reiterated: Hold | $46 → $52 | $50.38 | +3.23% | 11 | Oct 22, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $140 | $86.92 | +61.07% | 15 | Oct 7, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Buy | €280.00 | €292.70 | -4.34% | 8 | Oct 7, 2026 | |
| SWX: TECN Tecan Group AG | Reiterated: Buy | CHF 240.00 → CHF 300.00 | CHF 246.80 | +21.56% | 16 | Oct 2, 2026 | |
| ETR: FME Fresenius Medical Care AG | Downgraded: Hold | €42.00 | €39.04 | +7.58% | 1 | Sep 29, 2026 | |
| MRNA Moderna | Reiterated: Hold | $45 → $100 | $228.44 | -56.22% | 13 | Sep 10, 2026 |
Swedish Orphan Biovitrum AB (publ)
Nov 2, 2026
Reiterated: Buy
Price Target: kr 570.00 → kr 600.00
Current: kr 477.40
Upside: +25.68%
Fresenius SE & Co. KGaA
Oct 23, 2026
Reiterated: Buy
Price Target: €54.00
Current: €48.81
Upside: +10.63%
Qiagen
Oct 22, 2026
Reiterated: Hold
Price Target: $46 → $52
Current: $50.38
Upside: +3.23%
BioNTech SE
Oct 7, 2026
Reiterated: Buy
Price Target: $140
Current: $86.92
Upside: +61.07%
Sartorius Aktiengesellschaft
Oct 7, 2026
Reiterated: Buy
Price Target: €280.00
Current: €292.70
Upside: -4.34%
Tecan Group AG
Oct 2, 2026
Reiterated: Buy
Price Target: CHF 240.00 → CHF 300.00
Current: CHF 246.80
Upside: +21.56%
Fresenius Medical Care AG
Sep 29, 2026
Downgraded: Hold
Price Target: €42.00
Current: €39.04
Upside: +7.58%
Moderna
Sep 10, 2026
Reiterated: Hold
Price Target: $45 → $100
Current: $228.44
Upside: -56.22%